JPWO2023190199A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023190199A5
JPWO2023190199A5 JP2024512384A JP2024512384A JPWO2023190199A5 JP WO2023190199 A5 JPWO2023190199 A5 JP WO2023190199A5 JP 2024512384 A JP2024512384 A JP 2024512384A JP 2024512384 A JP2024512384 A JP 2024512384A JP WO2023190199 A5 JPWO2023190199 A5 JP WO2023190199A5
Authority
JP
Japan
Prior art keywords
seq
substitution
amino acid
pharmaceutical composition
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024512384A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023190199A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/011908 external-priority patent/WO2023190199A1/ja
Publication of JPWO2023190199A1 publication Critical patent/JPWO2023190199A1/ja
Publication of JPWO2023190199A5 publication Critical patent/JPWO2023190199A5/ja
Pending legal-status Critical Current

Links

JP2024512384A 2022-03-28 2023-03-24 Pending JPWO2023190199A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022052125 2022-03-28
PCT/JP2023/011908 WO2023190199A1 (ja) 2022-03-28 2023-03-24 スギタケレクチン及び／又はその変異ペプチドを含むウイルス感染症の治療用又は診断用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023190199A1 JPWO2023190199A1 (https=) 2023-10-05
JPWO2023190199A5 true JPWO2023190199A5 (https=) 2025-06-05

Family

ID=88201414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024512384A Pending JPWO2023190199A1 (https=) 2022-03-28 2023-03-24

Country Status (2)

Country Link
JP (1) JPWO2023190199A1 (https=)
WO (1) WO2023190199A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118834856B (zh) * 2024-07-25 2025-08-08 合肥中科健康生物产业技术研究院有限公司 一种α-L-岩藻糖苷酶突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5531290B2 (ja) * 2010-01-21 2014-06-25 株式会社Ｊ−オイルミルズ 遺伝子
JP6061424B2 (ja) * 2013-04-10 2017-01-18 株式会社Ａｖｓｓ レクチンを含むインフルエンザの治療剤
CN113631178A (zh) * 2018-09-06 2021-11-09 台湾地区“中央研究院” 抗病毒凝集素及其用途

Similar Documents

Publication Publication Date Title
Arai et al. Amino‐acid sequence of feather keratin from fowl
US10456462B2 (en) Vaccine against RSV
CZ200288A3 (cs) Hybridní polypeptid
JP2022514255A5 (https=)
Aimoto Contemporary methods for peptide and protein synthesis
US6713069B1 (en) Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
US20070219136A1 (en) Methods and compositions for treating inflammatory disorders
JPWO2023190199A5 (https=)
JP2008522954A5 (https=)
Mobley et al. The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes
WO2005002500A2 (en) Inhibitors of coronavirus
JP2025503079A5 (https=)
CA2582095A1 (en) Inhibitors of hepatitis c virus
EP1970379B1 (en) Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of hiv
WO2011110049A1 (zh) 抗hiv的融合多肽及其用途
CN117120459A (zh) 抗感染双环肽配体
Kiso et al. Amide formation, deprotection, and disulfide formation in peptide synthesis
JP2025509352A5 (https=)
US6489449B2 (en) Peptides for inhibition of HIV infection
WO2006025536A1 (ja) 抗sarsウイルス剤
PT99791B (pt) Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem
JP3770624B2 (ja) ウィルス感染・増殖抑制剤
WO2008050830A1 (fr) Agent anti-vih
JP3725899B6 (ja) Ｈｉｖに対して使用するための多分岐ペプチド構築物